[57Cr]sodium chromate (New England Nuclear, Boston, MA) for 1 h at 37°C were washed and mixed with various numbers of effector cells in round-bottomed microtiter wells at 104 target cells per well. For spontaneous release determination, medium was added to the wells; 1% Nonidet P-40 was added for maximum release determination. Plates were incubated for 6-8 h at 37 °C in a humidified atmosphere of 5% CO2, 95% air. At the end of the incubation, plates were centrifuged at 200 g for 5 rain, and 0.1 ml of the supernatant was collected and counted for radioactivity in a Beckman Gamma 5500 Counter (Beckman Instruments, Palo Alto, CA). Data are expressed as percent specific release: 100 × [(cpm experimental -cpm spontaneous)/(cpm maximum -cpm spontaneous)]. Spontaneous release was 16-28%. Standard deviations of quadruplicate replica samples were <10% of the mean, and are not shown.
Quantitation of Cell Surface
Antigens. For analysis of LCMV surface antigens, 5 × 10 ~ target cells were treated with mouse anti-LCMV antiserum at a final dilution of 1:50 in a volume of 150 ~1, and incubated 45 rain at 4°C. The cells were washed and then treated with 100 ~1 fluorescein isothiocyanate-conjugated goat anti-mouse Ig (Cappell Laboratories, Cochranville, PA) at 1:40 for 45 min at 4°C. The cells were washed and subjected to analysis by flow cytometry. Surface H-2 antigens were quantitated by the same method, using congenic anti-H-2 b (B10.A anti-B10) or anti-H-2 a (B10 anti-B10.D2) antisera obtained from Dr. Rolf Kiessling, Karolinska Institute, Stockholm, Sweden, and used at a final dilution of 1:60.
Results and Discussion
We inoculated C57BL/6 (H-2b), C3H/St (H-2k), or BALB/c (H-2 d) mice intraperitoneally with 107 plaque-forming units (PFU) VV strain WR or 8 × 104 PFU LCMV, strain Armstrong. 7 d later, the mice were killed and their spleen leukocytes were used as CTL effectors in cytotoxicity assays. The target cells were low-passage C57BL/6 or BALB/c MEF, or the continuous cell lines, L-929 (H-2 k) and MC57G (H-2b). Cells were either untreated, treated with IFN, infected with VV or LCMV, or infected and later tr.eated with IFN, as described in Materials and Methods. After radiolabeling with chromate, we used them as targets for CTL. The results in Fig. 1 , A-C indicate that pretreatment of VVor LCMV-infected MEF with 10,000 U/ml IFN-13 resulted in a substantial increase in the sensitivity of these targets to lysis by virus-specific CTL. IFN-i3 did not enhance the low levels of lysis observed with uninfected cells. Pretreatment with supernatants containing 64 U/ml IFN-7 generated from Con Astimulated spleen cells yielded virtually identical results (data not shown). Lysis of the virus-infected IFN-/3-treated targets was mediated by CTL, as it was H-2 restricted, and eliminated by pretreating the effectors with monoclonal anti-Thy-1.2 antibody and complement (C) (data not shown). In contrast to the results with T cell killing, IFN-/3 induced protection of both uninfected and LCMVinfected target cells against iysis by activated NK cells (Fig. 1, D and H ). This demonstration of IFN-mediated protection against NK cells indicates that IFN did not increase target cell sensitivity to lysis in general. Further, IFN-treated cells did not exhibit greater spontaneous release of label, and they were equally resistant to anti-LCMV antibody plus C-mediated lysis as compared with controls (data not shown).
We observed IFN-induced enhancement of sensitivity to CTL lysis with both C57BL/6 and BALB/c MEF, which suggests that this phenomenon may be a general property of low-passage MEF (Fig. 1, A-C) . However, IFN-/3 pretreatment of virus-infected continuous cell lines, i.e., LCMV-infected L-929 (Fig.  1E) , VV-infected L-929 (data not shown), LCMV-infected MC57G (Fig. 1 F VV-infected MC57G (Fig. 1 G) , did not enhance their sensitivity to lysis by CTL. This result was anticipated, as these targets are already highly sensitive to lysis by CTL. The structures recognized by virus-specific CTL are virus-induced surface proteins in association with class I MHC antigens (10). IFN is known to enhance the cell surface expression of both MHC (8, 9) and certain viral antigens (11) in some systems. To investigate the possibility that IFN was altering surface antigen expression on MEF, we quantitated surface H-2 and LCMV antigens by treating MEF with fluorescein-labeled antibodies and analyzing the cells by flow cytometry. IFN-3 pretreatment of MEF had no significant effect on the expression of surface LCMV antigens (data not shown), but both uninfected and LCMVinfected MEF had substantial increases in surface H-2 expression (Fig. 2, A, C,  and F) . Analysis of the continuous cell line MC57G also showed that surface expression of LCMV antigens remained unchanged after IFN-3 pretreatment (data not shown), but, in contrast to the MEF, MC57G cells had similar levels of surface H-2 antigens whether or not they were pretreated with IFN-3 (Fig. 2, B and D). Infection with LCMV had only a minor effect on this observation. MC57G cells were sensitive to other IFN-mediated effects, as IFN protected these cells from NK cell-mediated lysis (Fig. 1 H) . The level of surface H-2 on the untreated MC57G cells was similar to that on IFN-treated MEF, suggesting that MC57G cells may already express a level of surface H-2 antigens high enough for efficient association with viral antigens to be good targets for CTL. Treatment of MEF (Fig. 2E ) or MC57G cells (data not shown) with supernatants containing 64 U/ml IFN-~, generated from Con A-stimulated spleen cells yielded nearly identical results. IFN-induced enhancement of surface H-2 expression was dose dependent, and supernatants containing IFN-~ were more potent than IFN-3 as inducers of H-2 antigens (Table I) , in agreement with previously published observations (12) . Similarly, fewer units of IFN-y were needed to render targets more susceptible to iysis by CTL (Table I) .
Since MHC class I-restricted, virus-specific T cells are known to eliminate virus in vivo (13) , it is possible that IFN enhances this process by increasing the sensitivity of virus-infected cells to lysis by CTL. The source of the IFN could be either virus-induced IFN-a or IFN-3, or IFN-~" produced by T cells upon recognition of a target (14) . T cell-produced IFN-3, may locally enhance MHC expression in focal areas of infection, thereby increasing the sensitivity of T cell recognition of virus-infected tissue. Recent findings (15) show that IFN treatment of mice infected intracranially with LCMV leads to increased mortality. Since death in this system has been shown to be caused by virus-specific T celldependent destruction of brain tissue (16) , it is possible that IFN may be enhancing H-2 antigen expression on the surface of brain tissue (12) , leading to Various concentrations of IFN-/3 and Con A supernatant containing IFN-~' activity were added to LCMV-infected MEF. 24 h later, the MEF were used as targets in a CTL assay and also quantitated for surface H-2 expression by flow cytometry as described in Materials and Methods. 
Summary
Interferon (IFN) pretreatment of low-passage mouse embryonic fibroblasts (MEF) infected with lymphocytic choriomeningitis virus or vaccinia virus rendered these cells two to three times more susceptible to lysis by H-2 restricted, virus-specific cytotoxic T lymphocytes (CTL) than control, virus-infected MEF. The increased sensitivity to lysis correlated with increased expression of surface H-2 antigens, but not viral antigens. Continuous cell lines already highly sensitive to CTL-mediated lysis and already expressing high levels of surface H-2 antigens were unaffected by IFN pretreatment. These results suggest that IFN treatment, by increasing surface H-2 levels, may result in increased association of surface H-2 and virus antigens, leading to enhanced recognition and lysis by virus-
